In their comment on our report (1), Just et al. suggest that sample contamination explained mitochondrial DNA (mtDNA) heteroplasmy identified in some individuals (2). The authors further question the validity of our conclusions and the reliability of using massively parallel sequencing (MPS) to detect low-frequency heteroplasmy. We systematically evaluated the presence and impact of contamination and found that it only affects a small fraction of all individuals, leaving our original conclusions unchanged.
First, if contamination is common, the number of heteroplasmy per individual should approximate the number of mtDNA differences between randomly chosen individuals. However, the average number of pairwise mtDNA differences in the 1000 Genomes Project is 37, with a range of 20∼51 for within-population comparisons (Fig. 1A) . These results are much higher than the observed heteroplasmy number. Additionally, an elevated heteroplasmy number was not observed in Africans, who have the highest interindividual mtDNA differences (figure S11 in ref. 1).
Second, for each individual, we constructed two consensus sequences, covering the major and minor alleles at heteroplasmic sites, respectively, and we defined the haplogroup for both sequences based on PhyloTree (3). Although mutations creating a new haplogroup or erasing original haplogroup-defining alleles could occur, to be conservative we considered all individuals with a secondary haplogroup as being possibly contaminated. Overall, only 5.8% individuals are impacted (Table 1) .
Third, the remaining 1,022 individuals could be argued to be contaminated by a same-haplogroup sample, with private mutations contributing to heteroplasmy. However, among all within-population pairwise comparisons, only 2.2% have the same haplogroup. Other sources of contamination are unlikely to have a higher chance of having the same haplogroup as the sequenced sample than a random withinpopulation individual in the 1000 Genomes Project. The chance of having contamination multiplying by that of being in the same haplogroup yields minuscule probability.
Fourth, some of the 63 possibly contaminated individuals still carry real heteroplasmy. Because contaminated heteroplasmic sites should exhibit similar minor allele frequency (MAF), approximating the contamination fraction (for example, Fig. 1B ), real heteroplasmy could be detected by its clear deviation (for example, Fig. 1C ). Furthermore, enrichment of heteroplasmy on haplogroupdefining sites is not necessarily an indication of contamination because haplogroup-defining sites have much higher mutation rates than others (Fig. 1D) .
Our original conclusions remain unchanged even after excluding all 63 possibly contaminated individuals, mainly because 910 of 1,022 individuals carry heteroplasmy, yielding a prevalence estimate of 89.04% (originally reported as 89.68%). We still observed significant correlation between the relative mutation rate and heteroplasmy rate, even after applying an MAF cut-off of 15% (R 2 = 0.3, P < 2.2e-16). We do not understand why Just et al. (2) restricted their analysis to coding regions. We recognize the concerns of false positives in detecting heteroplasmy. However, 22 heteroplasmies identified in nine individuals with Illumina data were all observed with LS454 data at comparable frequencies ( figure S2 in ref. 1 
